Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Gabapentin NDC 76282-627 by Exelan Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image100mg - gabapentin capsules 100mg
This is a description of a medication called Gabapentin. It is available in capsule form containing 100mg of the active ingredient to treat specific conditions. The text includes details about the manufacturer and prescribing instructions for the medication.*
gabapentin capsules 300mg 1
Gabapentin Capsules USP is a prescription medication that is dispensed with an attached medication guide. Each capsule contains 300mg of gabapentin. The recommended dosage and usage information can be found in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) and it is manufactured by InvaGen Pharmaceuticals, Inc. for Exelan Pharmaceuticals, Inc.*
gabapentin capsules 300mg 2
This text describes a medication with the NDC code of 76282-627-90, which is a capsule containing 300 mg of Gabapentin. It indicates there is a package insert with full prescribing information, and the medication should be stored at controlled room temperature. The medication should be dispensed by a pharmacist with the attached medication guide. The medication is manufactured for the company EXELAN B Pamicetat, and is available by prescription only.*
image400mg - gabapentin capsules 400mg
Figure 1 - gabapentin capsules fig01
This is a table displaying the mean pain score for a 4-week dose titration period and a 4-week fixed dose period. The medications being compared are a placebo and Gabapentin, administered at a dosage of 3600mg/day. The numbers 1-8 represent the weeks of the study.*
Figure 2 - gabapentin capsules fig02
Figure 3 - gabapentin capsules fig03
This is a statistical figure representing the proportion of patients who responded to a certain treatment in two different studies related to PHN (Postherpetic Neuralgia). The data is displayed in a range from 0 to 100 in 10-point increments. The figure shows that in Study 1, 12% of patients had a reduction in pain score, while in Study 2, 32% had a reduction in pain score. The text also contains some monetary values, which may be relevant to the cost of treatment.*
Figure 4 - gabapentin capsules fig04
formula - gabapentin capsules formula
This is a formula used to calculate creatinine clearance (CLCr) which is an important measure of kidney function. It takes into account the person's age and weight, as well as their serum creatinine level. Female patients need to multiply the result by 0.85.*
Structural Formula - gabapentin capsules str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.